EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Botanical Sources: 12

Sweet wormwood Artemisia annua L.

Also called: sweet wormwood, annual wormwood, qing hao, sweet sagewort, Artemisia

Sweet wormwood is an annual herb used in traditional Chinese medicine and the plant source of artemisinin, from which the artemisinin antimalarial drugs are derived. Supplements use the leaves and upper shoots as tea, powders, capsules or extracts.

Category
Botanical
Part used
Leaves and upper shoots (aerial parts); teas, powders and extracts
Strongest evidence
C Limited
Native range
Native from North Africa to Eurasia (POWO: "N. Africa to Eurasia")
Reviewed
2026-10-29

Class 2 Moderately studied in people. No review counting single-ingredient trials was found. This entry cites 5 RCTs of Artemisia annua alone: sources [5], [6] and sources [10]–[12]; tea versus quinine or sulfadoxine-pyrimethamine for malaria, and extracts versus placebo or added to standard drugs. [10]

Fact-checked 2026-10-29 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

4 topics studied3 body areas · strongest grade C

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what Sweet wormwood does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for Sweet wormwood, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Malaria (whole-plant tea or powder instead of medicines)CWHO does not support use of Artemisia plant material in any form for malaria: content varies, is often insufficient to kill all parasites, and widespread use could hasten artemisinin resistance. [3]
Malaria parasite clearance in randomized trials of A. annua teaCA 2026 systematic review found rapid early parasite clearance, but day-28 parasitological outcomes with tea alone fell consistently below the 95.5-98.6% benchmark for artemisinin-based combination therapy. [4]
Hip and knee osteoarthritis painCPilot RCT (42 patients, 12 weeks): 150 mg extract twice daily improved WOMAC and pain scores from baseline; 300 mg twice daily and placebo did not. Authors called for further studies. [5]
Liver enzymes in adults with mild-to-moderate non-alcoholic liver dysfunctionCOne placebo-controlled trial of a powdered water extract (SPB-201) reported larger AST and ALT decreases than placebo at 4 and 8 weeks, with no significant adverse events. [6]

Main constituents: Artemisinin, described as the active constituent; its antimalarial effect involves free radicals formed by cleavage of its endoperoxide bond [1]; Artemisinins used as drugs (artesunate, artemether, artemisinin, dihydroartemisinin) are derivatives of this plant [2]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • Osteoarthritis pilot trial: 150 mg or 300 mg of an A. annua extract twice daily for 12 weeks. [5]
  • Pharmacokinetic study: one liter of tea made from 9 g of leaves, which contained 94.5 mg artemisinin. [7]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Score D
    A: well known causeE: unlikely cause

    LiverTox (Artemisinin chapter, updated 2017-02-08) gives artemisinin derivatives likelihood score D: possible rare cause of clinically apparent liver …

    Details and sources
  • Pregnancy and breastfeeding
    Safety data for pregnant or lactating women remain critically insufficient (2026 systematic review of A. annua tea).

    1 statement in the profile.

    Details and sources
  • Interactions with medicines
    1 listed

    CYP2B6 and CYP3A4 substrates

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    2 on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    None found

    No published information found in the sources checked.

    Details and sources
  • Liver injury: LiverTox rates artemisinin derivatives a possible rare cause of clinically apparent liver injury and states that most published hepatotoxicity reports were linked to herbal supplements containing artemisinin and extended use. [2]
  • Case reports include hepatitis after an artemisinin-containing herbal supplement and acute cholestatic hepatitis after artemisia tea taken for malaria prophylaxis; dermatitis has followed topical use. [1]
  • MSK advises that people with ulcers or gastrointestinal disorders should not take artemisia; reported side effects of supplements include dizziness and hearing problems. [1]
  • Safety data for children under five, pregnant or lactating women, and people with liver or kidney disease remain critically insufficient (2026 systematic review of A. annua tea). [4]
Interactions

Interactions

Known interactions of Sweet wormwood
WithWhat happens
Drugs metabolized by CYP2B6 or CYP3A4In laboratory studies, artemisia extracts induced CYP2B6 and CYP3A4 and may affect blood levels of drugs metabolized by these enzymes; clinical relevance has not been determined. [1]

Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.

Quality

Identity, quality and standardization

  • WHO states that the content of the Artemisia herbal remedies given for malaria treatment and prevention varies substantially and is often insufficient to kill all malaria parasites. [3]
Regulation

Regulatory status

  • US: FDA states that under DSHEA it does not have the authority to approve dietary supplements before they are marketed; firms are responsible for safety and labeling, and an NDI notification is required for certain new dietary ingredients. [8]
  • Artemisinin derivatives are drugs: LiverTox notes that in the United States the combination artemether (20 mg) with lumefantrine (120 mg) was approved in 2009 for P. falciparum malaria. [2]
  • WHO (2019) does not support the promotion or use of Artemisia plant material in any form for the prevention or treatment of malaria. [3]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • Artemisinin Sesquiterpene lactone; organic peroxide [P10]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • FDA's published NDI notification list has 2 entries naming Artemisia annua (earliest NDI 831 submitted 2014-05-13; most recent NDI 843 submitted 2014-07-01). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P2]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of Artemisia annua was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P3]
  • NTP technical reports list checked: no report on Artemisia annua or artemisinin. [P4]

Liver (NIH LiverTox)

  • LiverTox (Artemisinin chapter, updated 2017-02-08) gives artemisinin derivatives likelihood score D: possible rare cause of clinically apparent liver injury; most published hepatotoxicity reports were linked to herbal supplements containing artemisinin and extended treatment. [P5]
  • Case report: acute cholestatic hepatitis after artemisia tea taken as malaria prophylaxis. [P1]

Interactions with medicines

  • CYP2B6 and CYP3A4 substrates: Artemisia extracts induced CYP2B6 and CYP3A4 in laboratory studies; clinical relevance has yet to be determined. [P1]

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity test or examination of each component that is a dietary ingredient — 21 CFR 111.75(a)(1)(i) requires at least one appropriate test or examination to verify the identity of any component that is a dietary ingredient, unless FDA grants an exemption petition under (a)(1)(ii). [P6]
  • Artemisinin content assay — WHO states that the content of Artemisia herbal remedies given for malaria varies substantially and is often insufficient to kill all malaria parasites. [P7]

Supply and conservation

  • No published information found in the sources checked.

Absorption in people

  • In 14 healthy men who drank 1 L of tea from 9 g of leaves (94.5 mg artemisinin), mean peak plasma artemisinin was 240 ± 75 ng/mL and AUC 336 ± 71 ng/mL x hr; absorption was faster than from oral solid dosage forms, bioavailability similar. [P8]

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • No published information found in the sources checked.

Pregnancy and breastfeeding

  • Safety data for pregnant or lactating women remain critically insufficient (2026 systematic review of A. annua tea). [P9]

Sources for this profile

  1. Memorial Sloan Kettering Cancer Center. About Herbs: Artemisia annua (last updated April 15, 2026), 2026-04-15. mskcc.org
  2. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  3. IARC Monographs. List of Classifications (1,060 agents, Volumes 1-142; checked 2026-10-29), 2026-10-29. monographs.iarc.who.int
  4. National Toxicology Program (NIEHS). Technical Reports series list (607 reports; checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
  5. NIH LiverTox (NIDDK). Artemisinin (last update February 8, 2017; text read from the NCBI LitArch LiverTox archive NBK547852), 2017-02-08. ncbi.nlm.nih.gov
  6. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
  7. World Health Organization. The use of non-pharmaceutical forms of Artemisia (statement, 10 October 2019), 2019-10-10. who.int
  8. Räth K, et al. Pharmacokinetic study of artemisinin after oral intake of a traditional preparation of Artemisia annua L. (annual wormwood). Am J Trop Med Hyg 2004;70(2):128-32 (PMID 14993622), 2004-02. pubmed.ncbi.nlm.nih.gov
  9. Nkola JMW, et al. Phytochemical synergy in Artemisia annua herbal tea against malaria: a systematic review of its efficacy and safety. Infect Dis Poverty 2026;15(1):87 (PMID 42596018), 2026-08-13. pubmed.ncbi.nlm.nih.gov
  10. PubChem (NCBI). Artemisinin, CID 68827: compound description from ChEBI (retrieved 2026-10-29), 2026-10-29. pubchem.ncbi.nlm.nih.gov
Sources

Sources

  1. Memorial Sloan Kettering Cancer Center. About Herbs: Artemisia annua (last updated April 15, 2026), 2026-04-15. mskcc.org
  2. NIH LiverTox (NIDDK). Artemisinin (last update February 8, 2017; text read from the NCBI LitArch LiverTox archive NBK547852), 2017-02-08. ncbi.nlm.nih.gov
  3. World Health Organization. The use of non-pharmaceutical forms of Artemisia (statement, 10 October 2019), 2019-10-10. who.int
  4. Nkola JMW, et al. Phytochemical synergy in Artemisia annua herbal tea against malaria: a systematic review of its efficacy and safety. Infect Dis Poverty 2026;15(1):87 (PMID 42596018), 2026-08-13. pubmed.ncbi.nlm.nih.gov
  5. Stebbings S, et al. A pilot randomized, placebo-controlled clinical trial of an extract of Artemisia annua over 12 weeks for osteoarthritis of the hip and knee. Clin Rheumatol 2016;35(7):1829-36 (PMID 26631103), 2016-07. pubmed.ncbi.nlm.nih.gov
  6. Han B, et al. A randomized, double-blind, placebo-controlled, multi-centered clinical study of Artemisia annua L. extract for improvement of liver function. Clin Nutr Res 2020;9(4):258-270 (PMID 33204666), 2020-10-28. pubmed.ncbi.nlm.nih.gov
  7. Räth K, et al. Pharmacokinetic study of artemisinin after oral intake of a traditional preparation of Artemisia annua L. (annual wormwood). Am J Trop Med Hyg 2004;70(2):128-32 (PMID 14993622), 2004-02. pubmed.ncbi.nlm.nih.gov
  8. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
  9. Plants of the World Online (POWO), Royal Botanic Gardens, Kew. Artemisia annua L.: accepted name and native range as recorded in WCVP, the taxonomic index of POWO (WCVP Darwin Core archive, GBIF dataset f382f0ce-323a-4091-bb9f-add557f3a9a2, published 2026-06-04; read 2026-10-29), 2026-06-04. powo.science.kew.org
  10. Mueller MS, et al. Randomized controlled trial of a traditional preparation of Artemisia annua L. (Annual Wormwood) in the treatment of malaria. Trans R Soc Trop Med Hyg 2004;98(5):318-21 (PMID 15109558), 2004-05. pubmed.ncbi.nlm.nih.gov
  11. Blanke CH, et al. Herba Artemisiae annuae tea preparation compared to sulfadoxine-pyrimethamine in the treatment of uncomplicated falciparum malaria in adults: a randomized double-blind clinical trial. Trop Doct 2008;38(2):113-6 (PMID 18453510), 2008-04. pubmed.ncbi.nlm.nih.gov
  12. Yang M, et al. Effect of Artemisia annua extract on treating active rheumatoid arthritis: a randomized controlled trial. Chin J Integr Med 2017;23(7):496-503 (PMID 28035541), 2017-07. pubmed.ncbi.nlm.nih.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in botanical: Aloe vera · American ginseng · Amla · Andrographis · Arjuna · Arnica · Aronia (black chokeberry) · Asafoetida · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.